Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, @UCSFCancer on whether there are emerging mutations in FLT3 mutated relapsed/refractory acute myeloid leukemia (AML) that respond to gilteritinib.
Common Mutations Associated with Gilteritinib Resistance @UCSFCancer
